ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Bansi Koul
Stig Steen
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koul, B.
Right arrow Articles by Steen, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koul, B.
Right arrow Articles by Steen, S.

Ann Thorac Surg 1992;53:1046-1051
© 1992 The Society of Thoracic Surgeons


Articles

Twenty-four-hour heparin-free veno-right ventricular ECMO: An experimental study

Bansi Koul, MD*,a,b, Ole Vesterqvist, PhDa,b, Nils Egberg, MDa,b, Stig Steen, MDa,b

a Thoracic Surgical Clinic, University Hospital, Lund Sweden
b Departments of Clinical Chemistry and Blood Coagulation, Karolinska Hospital, Stockholm, Sweden

Accepted for publication November 29, 1991.

* Address reprint requests to Dr Koul, Thoracic Surgical Clinic, University Hospital, 221 85 Lund, Sweden.

Platelets and coagulation factors were studied during 24-hour heparin-free veno-right ventricular extracorporeal membrane oxygenation (ECMO) in 6 healthy pigs. An endpoint attached and covalently bonded heparin-coated ECMO system was used in these experiments. The veno-right ventricular ECMO supplied the total lung function of the animals, and after 24 hours, all the animals were successfully weaned from ECMO. Lung function and central hemodynamics were not affected by the procedure. Because all the animals showed a significant reduction in plasma volume, the concentration of measured coagulation variables was corrected both for plasma volume changes and for hemodilution. The platelet count and the plasma-free hemoglobin level were not significantly altered by ECMO. Similarly, the prothrombin complex, antithrombin, thrombin-antithrombin complex, factor XII, and the urinary excretion of 2,3-dinor-thromboxane B2 were not significantly altered. Fibrinogen and fibrin monomer increased significantly, whereas von Willebrand factor was significantly decreased after ECMO. In summary, 24-hour heparin-free veno-right ventricular total extracorporeal lung assistance does not affect the platelets and the coagulation system significantly in healthy juvenile pigs.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
S. F. Aranki, D. H. Adams, R. J. Rizzo, G. S. Couper, M. M. DeCamp, D. J. Fitzgerald, and L. H. Cohn
Femoral veno-arterial extracorporcal life support with minimal or no heparin
Ann. Thorac. Surg., July 1, 1993; 56(1): 149 - 155.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Steen, T. Sjoberg, G. Massa, L. Ericsson, and L. Lindberg
Safe pulmonary preservation for 12 hours with low-potassium-dextran solution
Ann. Thorac. Surg., February 1, 1993; 55(2): 434 - 440.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1992 by The Society of Thoracic Surgeons.